Active Ingredient: NALOXONE HYDROCHLORIDE
Proprietary Name: NALOXONE HYDROCHLORIDE
Dosage Form; Route of Administration: SPRAY, METERED; NASAL
Strength: 4MG/SPRAY
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A211951
Product Number: 001
Approval Date: Jun 21, 2022
Applicant Holder Full Name: PADAGIS ISRAEL PHARMACEUTICALS LTD
Marketing Status:
Over-the-counter
Patent and Exclusivity Information
